A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair

Stopped early · Phase 4

Conditions studied: Pain Control

In brief

The purpose of this study is to identify a dose of intrathecal hydromorphone (opioid pain medicine) that optimizes pain control but minimizes side effects historically seen with this class of pain medications.

Key facts

Study ID

NCT05552443

Run by

Mayo Clinic

People needed

31

Starts

2023-03-23

Expected to finish

2024-12-31

Last updated by the study team

2026-05-14

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing spinal surgery with a posterior approach for idiopathic scoliosis.

You may not qualify if…

• Patients with pre-surgical elevated pain scores (≥ 3/10 on Numeric Rating Scale (NRS)), history of chronic pain, or pre-surgical opioid use will not be included.
• Patients with contraindications to spinal anesthesia (anatomical abnormality or elevated bleeding or infection risks) will not be included.
• Patients for whom the protocol is violated (inability to perform postoperative data collection), or the study/procedure was aborted will not be included in analysis.

Where it is running

• Mayo Clinic Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.